Breast Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are 18 years of age or older
- People diagnosed with a specific type of breast cancer known as HR-positive, HER2-negative (this refers to the hormone and protein markers found on the cancer cells)
- Women with Stage II or Stage III breast cancer (meaning the cancer has not spread to distant parts of the body) who are being admitted for breast cancer treatment for the first time
- People whose treating doctor has determined they will receive one of the standard chemotherapy treatment combinations used in this trial
- People whose full medical history is available and on record
- People with a general health and functioning score of 70 or above on a standard medical scale, meaning they are able to carry out normal daily activities with some difficulty at most (confirm with trial site)
Who may not be able to join:
- Women who have already received any type of cancer treatment, including chemotherapy, radiation therapy, targeted therapy, or hormone therapy
- Women who are pregnant or currently breastfeeding
- People diagnosed with cancer in both breasts at once, inflammatory breast cancer, or occult breast cancer (a rare form where the primary tumour is difficult to detect)
- People diagnosed with Stage IV breast cancer, meaning the cancer has spread to distant parts of the body
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Caigang Liu, PHD, Shengjing Hospital
Phone: +8618940256668
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Total pathological complete response (tpCR)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.